Yonhap Infomax NewsDec 29
Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
#YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97468
Global Pharma Firms Pay to Get in Line for Alteogen’s Technology—Target Price Set at 730,000 Won

Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.

Yonhap Infomax
ALLi Blog (unofficial)Jan 24, 2022
The Ultimate Guide to Option Agreements for Indie Authors https://selfpublishingadvice.org/option-agreements/ #PublishingRights&Contracts #optionagreement #self-publishing #bookrights #contracts #subrights #movie #film
The Ultimate Guide to Option Agreements for Indie Authors

Option agreements are the stuff of author dreams. With thanks to Silvia Schimdt for writing The Ultimate Guide to Option Agreements.

Alliance of Independent Authors: Self-Publishing Advice Center